文献速递肺外科

机器人与胸腔镜肺叶切除术长期生存比较

A Comparative Analysis of Long-Term Survival of Robotic Versus Thoracoscopic Lobectomy.
PubMed 文献 · Ann Thorac Surg · 2020-05-01

该研究基于SEER-Medicare数据库,对2008至2013年接受微创肺叶切除术的非小细胞肺癌患者进行倾向性匹配分析,比较机器人辅助与胸腔镜手术的长期生存。匹配后每组409例,中位随访35个月,两组总生存率和癌症特异性死亡率均无显著差异。结论认为两种微创入路的肿瘤学结局相似,仍需随机对照试验进一步验证。

要点

  • 机器人辅助与胸腔镜肺叶切除术的长期总生存无显著差异。
  • 两组癌症特异性死亡率在3年时亦无统计学差异。
  • 现有证据支持两种微创术式肿瘤学效果相当,但需随机试验确认。

核心结论

  • 倾向性匹配分析显示机器人辅助肺叶切除术与胸腔镜肺叶切除术的总生存和癌症特异性死亡率相似。

研究设计与样本

  • 基于SEER-Medicare数据库的倾向性匹配分析,纳入2008至2013年接受微创肺叶切除术的非小细胞肺癌患者,胸腔镜组3881例,机器人组426例,按人口学、合并症、治疗和肿瘤特征1:1匹配。

主要发现

  • 匹配队列每组409例,手术中位年龄73岁(范围65-91),术后中位随访35个月。

临床怎么用

  • 在缺乏随机对照试验证据时,机器人辅助与胸腔镜肺叶切除术均可作为非小细胞肺癌的微创选择,长期肿瘤学结局相似。

局限性

  • 回顾性数据库分析,可能存在未测量混杂。
  • 作者指出需随机对照试验、其变体或更多大规模注册分析验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive lobectomy can be performed robotically or thoracoscopically. Short-term outcomes between the 2 approaches are reported to be similar; however, the comparative oncological effectiveness is not known. We sought to compare long-term survival after robotic and thoracoscopic lobectomy. METHODS: We performed a propensity-matched analysis of SEER (Surveillance, Epidemiology and End Results)-Medicare patients with non-small cell lung cancer from 2008 to 2013 who underwent minimally invasive lobectomy using either a thoracoscopic (n = 3881) or a robotic-assisted (n = 426) approach. Patients in the 2 groups were propensity matched 1:1 based on demographics, comorbidities, treatment, and tumor characteristics. We compared the overall survival (OS) and cancer-specific mortality (CSM) between the 2 groups. RESULTS: Within the matched cohort (n = 409 per group), the median age at surgery was 73 (range, 65-91) years, with a median follow-up of 35 months postsurgery. There was no difference in OS or CSM between the thoracoscopic and robotic-assisted groups (OS: 71.4% vs 73.1% at 3 years, overall P = .366; CSM: 16.6% vs 14.9% at 3 years, overall P = .639). CONCLUSIONS: Our propensity-matched analysis demonstrates that patients undergoing robotic-assisted lobectomy have similar OS and CSM compared with those patients undergoing thoracoscopic lobectomy. Oncologic outcomes are similar between the 2 minimally invasive approaches. These results demonstrate that further investigation is needed in the form of a randomized control trial, its variations, or additional large-scale registry analyses to verify these results.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sesti J, Langan RC, Bell J, et al. A Comparative Analysis of Long-Term Survival of Robotic Versus Thoracoscopic Lobectomy. Ann Thorac Surg. 2020. PMID: 32360876. doi:10.1016/j.athoracsur.2020.03.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。